What is the life expectancy of someone with Costello Syndrome?

Life expectancy for individuals with Costello syndrome is variable and depends significantly on the presence and severity of specific medical complications, particularly cardiac issues and malignancy. While individuals with Costello syndrome face increased health risks, proactive, multidisciplinary care has substantially improved long-term outcomes and quality of life in recent decades.

What factors influence life expectancy in Costello syndrome?

The prognosis for Costello syndrome is heavily influenced by the management of systemic complications. The most critical factors affecting longevity include the severity of hypertrophic cardiomyopathy, the risk of developing certain tumors (such as rhabdomyosarcoma or neuroblastoma), and the presence of severe feeding difficulties or respiratory issues in early childhood. Because Costello syndrome is a multisystem disorder, life expectancy is not determined by a single factor but by the cumulative impact of these comorbidities.

How have outcomes for Costello syndrome changed?

Over the last 20 years, advancements in clinical surveillance protocols have significantly altered the trajectory of Costello syndrome. Early identification of cardiac arrhythmias and routine cancer screening allow for timely interventions that were previously unavailable. While Costello syndrome remains a complex condition, these improved management strategies mean that many individuals are now reaching adulthood with a much better quality of life than historical data suggested.

What is the importance of regular medical follow-up?

Because Costello syndrome can affect almost every organ system, consistent, lifelong medical surveillance is essential. Proactive care involves a team of specialists to manage the specific risks associated with the condition:

• Regular echocardiograms to monitor for hypertrophic cardiomyopathy and valvular issues.


• Age-appropriate cancer screening protocols to detect tumors early when they are most treatable.


• Multidisciplinary support for developmental delays, physical therapy, and nutritional management.


• Endocrine evaluations to monitor for growth hormone deficiency and metabolic needs.

How do we define quality of life in Costello syndrome?

For those living with Costello syndrome, longevity is only one component of a successful clinical outcome. Our community of 13 members at DiseaseMaps.org highlights that focusing on social integration, cognitive support, and physical comfort is equally vital. By shifting the focus from purely numerical life expectancy to holistic care, we can better support the unique potential of every individual with Costello syndrome.

Next steps

• Consult with a geneticist or a specialist in RASopathies to establish a personalized surveillance plan.


• Join the DiseaseMaps.org community to connect with other families navigating the complexities of Costello syndrome.


• Ensure you have a dedicated care coordinator to manage appointments across cardiology, oncology, and neurology.

Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Costello Syndrome Overview.


• Orphanet: Costello Syndrome (ORPHA:205).


• OMIM (Online Mendelian Inheritance in Man): #218040 Costello Syndrome.


• Costello Syndrome Family Network: Clinical Management Guidelines.